1. Home
  2. CHMI vs MXCT Comparison

CHMI vs MXCT Comparison

Compare CHMI & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.60

Market Cap

97.0M

Sector

Real Estate

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.86

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
MXCT
Founded
2012
1999
Country
United States
United States
Employees
14
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.0M
93.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CHMI
MXCT
Price
$2.60
$0.86
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$3.00
$5.50
AVG Volume (30 Days)
188.8K
865.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
15.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$61.13
$18.50
P/E Ratio
$139.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$0.64
52 Week High
$3.14
$2.96

Technical Indicators

Market Signals
Indicator
CHMI
MXCT
Relative Strength Index (RSI) 45.29 57.55
Support Level $2.50 $0.65
Resistance Level $2.76 $0.88
Average True Range (ATR) 0.05 0.05
MACD -0.00 0.01
Stochastic Oscillator 31.25 82.54

Price Performance

Historical Comparison
CHMI
MXCT

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: